Background illustration for clinical trials search

Paid Clinical Trials Cleveland

Discover 1,397 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment

for
Advanced Solid Tumors, Hematologic Malignancies
Location: Canton OH, Detroit MI, Chicago IL
Sponsor: Acrotech Biopharma Inc.

Sex: All

Age: 18+

Code: NCT07036133

Phase1, Recruiting

A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States

for
Advanced Unresectable Gastric Adenocarcinoma,
Location: Canton OH, St Louis MO, Coral Springs FL, Tamarac FL,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07554521

Phase2, Recruiting

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Canton OH, Hinsdale IL, Wilson NC, Pinehurst NC,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06899126

Phase3, Recruiting

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

for
Metastatic Castration Resistant Prostate Cancer
Location: Canton OH, Holland MI, Jeffersonville IN, Charlotte NC,
Sponsor: ORIC Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07723248

Phase3, Recruiting

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: Canton OH, Detroit MI, Chicago IL, Florham Park NJ,
Sponsor: Oncolytics Biotech

Sex: All

Age: 18+

Code: NCT07446322

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

for
Polycythemia Vera
Location: Canton OH, Grand Rapids MI, Bethesda MD, The Bronx NY,
Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT07429266

Phase3, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Canton OH, Detroit MI, Dayton OH, Toronto, Oshawa,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase3, Recruiting

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

for
HR+/HER2- Breast Cancer
Location: Canton OH, Detroit MI, Dayton OH, Fort Wayne IN,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07492641

Phase3, Recruiting

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

for
Metastatic Pancreatic Adenocarcinoma
Location: Canton OH, Tampa FL, Whittier CA
Sponsor: Eleison Pharmaceuticals LLC.

Sex: All

Age: 18+

Code: NCT01954992

Phase3, Recruiting

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

for
Neoplasms, Neoplasm Metastasis, Non-Small-Cell Lung Cancer
Location: Canton OH, Detroit MI, Boston MA
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.

Sex: All

Age: 18+

Code: NCT03797391

Phase1, Phase2, Recruiting

A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

for
Triple Negative Breast Cancer
Location: Canton OH, Columbus GA, Springfield MO
Sponsor: Jina Pharmaceuticals Inc.

Sex: Female

Age: 18 - 65

Code: NCT03671044

Phase3, Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

for
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma,
Location: Canton OH, Pittsburgh PA, Columbus OH, Fairfax VA,
Sponsor: OncoNano Medicine, Inc.

Sex: All

Age: 18+

Code: NCT06022029

Phase1, Recruiting

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

for
Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations,
Location: Canton OH, Brampton, Fairfax VA, Milwaukee WI,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05967689

Phase2, Recruiting

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

for
Breast Cancer, TNBC - Triple-Negative Breast Cancer,
Location: Canton OH, Dyer IN, Baltimore MD, New Brunswick NJ,
Sponsor: Processa Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06568692

Phase2, Recruiting

KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment

for
Primary Myelofibrosis (PMF),
Location: Canton OH, Chicago IL, Milwaukee WI, New York NY,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT03662126

Phase2, Phase3, Recruiting

Pan-tumor MRD Study

for
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer,
Location: Canton OH, Maumee OH, Grand Rapids MI, Sayre PA,
Sponsor: Paradigm Health

Sex: All

Age: 18+

Code: NCT06605404

Recruiting

Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies

for
B-Cell Malignancies
Location: Canton OH
Sponsor: TransThera Sciences (Nanjing), Inc.

Sex: All

Age: 18+

Code: NCT05275504

Phase1, Recruiting

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

for
Advanced Melanoma
Location: Canton OH, Pittsburgh PA, Toronto, Bethesda MD,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18+

Code: NCT06697301

Phase2, Phase3, Recruiting

Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis

for
Primary Myelofibrosis (PMF),
Location: Canton OH, Houston TX, Glendale CA, Whittier CA
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04878003

Phase2, Recruiting

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

for
Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer,
Location: Canton OH, Detroit MI, Fairfax VA, St Louis MO
Sponsor: Sairopa B.V.

Sex: All

Age: 18+

Code: NCT05856981

Phase1, Recruiting